Ibrahim Abdelwahab's Colleagues at LEXEO Therapeutics
Peter Graham
Associate Director, Program and Portfolio Management at LEXEO Therapeutics
Ibrahim Abdelwahab's Contact Details
212-547-9879
New York,New York,United States
LEXEO Therapeutics
Ibrahim Abdelwahab's Company Details
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO's foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medical College and the University of California, San Diego, two preeminent institutions on the cutting edge of gene therapy research. LEXEO is advancing a deep and diverse pipeline of AAV-based gene therapy candidates in rare cardiovascular diseases, APOE4-associated Alzheimer's disease, and CLN2 Batten disease, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.